28/08/2024  22:10:00 Var. -1.05 Volume Denaro00:00:00 Lettera00:00:00 Capitalizzazione di mercato Dividend Y. Rapporto P/E
247.55USD -0.42% 727,038
Fatturato: 114.86 mill.
188.66Quantità in denaro: 100 255.00Quantità in lettera: 200 45.13 bill.USD - 33.50

Descrizione business

IQVIA is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Ari Bousbib
Consiglio di amministrazione
Ron Bruehlman, Trudy Stein, Karl Guenault, Kevin Knightly, Sanjay Chikarmane, Jim Berkshire, Eric Sherbet
Consiglio di sorveglianza
Ari Bousbib, Carol J. Burt, John P. Connaughton, John G. Danhakl, James A. Fasano, Colleen Goggins, John M. Leonard, Leslie Wims Morris, Todd B. Sisitsky, Sheila A. Stamps
 

Dati aziendali

Name: IQVIA Holdings Inc.
Indirizzo: 2400 Ellis Road,Durham, North Carolina 27703,USA
Telefono: +1-203-448-4663
Fax: -
E-mail: -
Internet: https://www.iqvia.com/
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: -
Data dell'IPO: -

Rapporti con gli investitori

Name: Nick Childs
IR telefono: +1-973-316-3828
IR Fax: -
IR e-mail: ir@iqvia.com

Principali azionisti

Altri
 
58.37%
Vanguard Group
 
11.56%
BlackRock Inc.
 
8.32%
HARRIS ASSOCIATES L P
 
5.35%
State Street Corporation
 
4.34%
ALLIANCEBERNSTEIN L P
 
2.60%
Morgan Stanley
 
2.22%
GEODE CAPITAL MANAGEMENT LLC
 
2.21%
LAZARD ASSET MANAGEMENT LLC
 
1.77%
Altri
 
3.26%